Spontaneous bacterial peritonitis: An update

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Objective: To describe spontaneous bacterial peritonitis (SBP) in the context of currently accepted criteria for diagnosis, treatment, and prevention. Design: A review of SBP and its associated etiopathogenic factors is presented. Material and Methods: Numerous studies on mechanisms of disease, diagnosis, treatment, and prevention are discussed. Diagnostic and therapeutic algorithms are presented. Results: Peritonitis in patients with ascites in the absence of secondary causes, such as perforation of a viscus, occurs primarily in patients with end-stage liver disease. Enteric organisms, mainly gram-negative bacilli, probably translocate to regional lymph nodes to produce bacteremia and seeding of ascitic fluid. Signs and symptoms of peritonitis are usually subtle. The ascitic fluid polymorphonuclear leukocyte count is the best determinant for early diagnosis and treatment of SBP. Third-generation cephalosporins such as cefotaxime are considered the drugs of choice for treatment, whereas quinolones such as norfloxacin are used to decrease recurrence. Conclusion: Despite increased awareness, early diagnosis, and prompt and effective antimicrobial therapy, SBP recurs frequently and is associated with a high mortality rate. Patients with SBP should be assessed for candidacy for liver transplantation.

Original languageEnglish (US)
Pages (from-to)365-370
Number of pages6
JournalMayo Clinic Proceedings
Volume70
Issue number4
StatePublished - 1995

Fingerprint

Peritonitis
Ascitic Fluid
Early Diagnosis
Therapeutics
Norfloxacin
End Stage Liver Disease
Viscera
Cefotaxime
Quinolones
Cephalosporins
Bacteremia
Leukocyte Count
Ascites
Liver Transplantation
Bacillus
Signs and Symptoms
Neutrophils
Lymph Nodes
Recurrence
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Spontaneous bacterial peritonitis : An update. / Gilbert, J. A.; Kamath, Patrick Sequeira.

In: Mayo Clinic Proceedings, Vol. 70, No. 4, 1995, p. 365-370.

Research output: Contribution to journalArticle

@article{7586d8460f3a4083ac258a5bdb3e4ca4,
title = "Spontaneous bacterial peritonitis: An update",
abstract = "Objective: To describe spontaneous bacterial peritonitis (SBP) in the context of currently accepted criteria for diagnosis, treatment, and prevention. Design: A review of SBP and its associated etiopathogenic factors is presented. Material and Methods: Numerous studies on mechanisms of disease, diagnosis, treatment, and prevention are discussed. Diagnostic and therapeutic algorithms are presented. Results: Peritonitis in patients with ascites in the absence of secondary causes, such as perforation of a viscus, occurs primarily in patients with end-stage liver disease. Enteric organisms, mainly gram-negative bacilli, probably translocate to regional lymph nodes to produce bacteremia and seeding of ascitic fluid. Signs and symptoms of peritonitis are usually subtle. The ascitic fluid polymorphonuclear leukocyte count is the best determinant for early diagnosis and treatment of SBP. Third-generation cephalosporins such as cefotaxime are considered the drugs of choice for treatment, whereas quinolones such as norfloxacin are used to decrease recurrence. Conclusion: Despite increased awareness, early diagnosis, and prompt and effective antimicrobial therapy, SBP recurs frequently and is associated with a high mortality rate. Patients with SBP should be assessed for candidacy for liver transplantation.",
author = "Gilbert, {J. A.} and Kamath, {Patrick Sequeira}",
year = "1995",
language = "English (US)",
volume = "70",
pages = "365--370",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "4",

}

TY - JOUR

T1 - Spontaneous bacterial peritonitis

T2 - An update

AU - Gilbert, J. A.

AU - Kamath, Patrick Sequeira

PY - 1995

Y1 - 1995

N2 - Objective: To describe spontaneous bacterial peritonitis (SBP) in the context of currently accepted criteria for diagnosis, treatment, and prevention. Design: A review of SBP and its associated etiopathogenic factors is presented. Material and Methods: Numerous studies on mechanisms of disease, diagnosis, treatment, and prevention are discussed. Diagnostic and therapeutic algorithms are presented. Results: Peritonitis in patients with ascites in the absence of secondary causes, such as perforation of a viscus, occurs primarily in patients with end-stage liver disease. Enteric organisms, mainly gram-negative bacilli, probably translocate to regional lymph nodes to produce bacteremia and seeding of ascitic fluid. Signs and symptoms of peritonitis are usually subtle. The ascitic fluid polymorphonuclear leukocyte count is the best determinant for early diagnosis and treatment of SBP. Third-generation cephalosporins such as cefotaxime are considered the drugs of choice for treatment, whereas quinolones such as norfloxacin are used to decrease recurrence. Conclusion: Despite increased awareness, early diagnosis, and prompt and effective antimicrobial therapy, SBP recurs frequently and is associated with a high mortality rate. Patients with SBP should be assessed for candidacy for liver transplantation.

AB - Objective: To describe spontaneous bacterial peritonitis (SBP) in the context of currently accepted criteria for diagnosis, treatment, and prevention. Design: A review of SBP and its associated etiopathogenic factors is presented. Material and Methods: Numerous studies on mechanisms of disease, diagnosis, treatment, and prevention are discussed. Diagnostic and therapeutic algorithms are presented. Results: Peritonitis in patients with ascites in the absence of secondary causes, such as perforation of a viscus, occurs primarily in patients with end-stage liver disease. Enteric organisms, mainly gram-negative bacilli, probably translocate to regional lymph nodes to produce bacteremia and seeding of ascitic fluid. Signs and symptoms of peritonitis are usually subtle. The ascitic fluid polymorphonuclear leukocyte count is the best determinant for early diagnosis and treatment of SBP. Third-generation cephalosporins such as cefotaxime are considered the drugs of choice for treatment, whereas quinolones such as norfloxacin are used to decrease recurrence. Conclusion: Despite increased awareness, early diagnosis, and prompt and effective antimicrobial therapy, SBP recurs frequently and is associated with a high mortality rate. Patients with SBP should be assessed for candidacy for liver transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0028903525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028903525&partnerID=8YFLogxK

M3 - Article

C2 - 7898143

AN - SCOPUS:0028903525

VL - 70

SP - 365

EP - 370

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 4

ER -